Table 4.
The changes in the serum inflammation markers.
| Group | CG (n = 13) | EG (n = 13) | Time × Group Interaction |
|||
|---|---|---|---|---|---|---|
| Variables | Baseline | 12-Week | Baseline | 12-Week | F | p |
| NF-κB (ng/mL) | 4.66 ± 1.61 | 4.78 ± 1.68 | 4.51 ± 1.36 | 4.23 ± 1.24 # | 6.084 | 0.021 * |
| CV | 0.35 | 0.35 | 0.30 | 0.29 | ||
| IFN-γ (pg/mL) | 10.12 ± 3.57 | 11.20 ± 4.15 | 9.96 ± 3.82 | 7.85 ± 2.80 ∫ | 6.764 | 0.016 * |
| CV | 0.35 | 0.37 | 0.38 | 0.36 | ||
Data are presented as mean ± standard deviation. CG, control group; EG, experimental group; CV, coefficient of variation; NF-κB, nuclear factor Kappa B; IFN-γ, interferon-gamma; # Compared with baseline values within EG (p < 0.05); ∫ Compared with corresponding values in CG (p < 0.05); * p < 0.05.